NOTE: The content below contains the first few paragraphs of the printed article and the titles of the sidebars and boxes, if applicable.
Eisai Hires and Promotes
Eisai, Teaneck, N.J., the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co. Ltd., has made several staff appointments. Linda DaSilva has been promoted to senior director, corporate planning, responsible for establishing and implementing corporate strategies and strategic projects. Previously, she was senior director, pharmacy and trade relations. Kristina Duke has been named district manager of hospital sales for New York City. Terri Fortenberry has joined Eisai as senior district manager, neurology sales, for the Houston district. Sean Spears has been promoted to senior director, pharmacy and trade relations, responsible for working with pharmacy wholesalers and chain customers. Previously, he was director of trade relations. Before joining Eisai, Mr. Spears was employed at Mylan Bertek Pharmaceuticals, most recently overseeing trade relations and specialty pharmacy. David Vaught has been hired as director, regional account management (West). Cathy Zhang also has been hired as manager, government contracting. Richard A. Gonzalez Abbott Changes Leadership Abbott, a global, broad-based healthcare company with headquarters in Abbott Park, Ill., has appointed Richard A. Gonzalez as president and chief operating officer. Mr. Gonzalez replaces Jeffrey M. Leiden, M.D., Ph.D., who stepped down to pursue other career interests. Mr. Gonzalez, a 29-year Abbott veteran, previously was president and chief operating officer of the medical products group. Abbas Hussain Rich Pilnik Lilly Makes Senior Leadership Changes Eli Lilly, Indianapolis, an innovation-driven pharmaceutical developer, has appointed Abbas Hussain as president of European operations. Since joining Lilly in 1988, Mr. Hussain has held multiple leadership positions throughout Europe. Most recently, he was regional VP. He holds a joint degree in medicinal chemistry and pharmacology from Loughborough University. He succeeds Rich Pilnik, who has been named group VP and chief marketing officer for the company. Mr. Pilnik oversees Lilly’s global strategy for sales and marketing. He also has joined the company’s operations committee. Mr. Pilnik joined Lilly in 1983 and has achieved strong sales and marketing results in multiple countries. He has a B.A. in economics from Duke University and an MBA from Northwestern University. Dr. Nancy Joseph-Ridge TAP Names Executive to Lead R&D Nancy Joseph-Ridge, M.D., has been named VP of research and development at TAP Pharmaceutical Products. TAP, Lake Forest, Ill., is a joint venture between Abbott Laboratories and Takeda Pharmaceutical. Dr. Joseph-Ridge, 47, has been with TAP since 2002. Most recently, she was therapeutic area head, internal medicine and rheumatology, and department head, publications, medical writing, and clinical-trial registries. Previously, she worked for Searle in drug safety and clinical development. She earned her M.D. from the University of Illinois at Chicago. Peter Loescher Merck Adds President, Global Human Health Merck, a global, research-driven pharmaceutical company based in Whitehouse Station, N.J., has appointed Peter Loescher to the newly created position of president, global human health. He has direct responsibility for Merck’s four marketing and sales divisions. Mr. Loescher, 48, most recently served as president and CEO of GE Healthcare Bio-Sciences. Dr. Hilary Malone Bernard Poussot Wyeth Hires and Promotes Wyeth, a research-driven pharmaceutical and healthcare products company based in Madison, N.J., has appointed Hilary Malone, Ph.D., as senior VP, global regulatory affairs, at Wyeth Pharmaceuticals. Previously, she was VP, European regulatory affairs, at Astra Zeneca. Dr. Malone received her doctorate in neuropharmacology from Dundee University in Scotland followed by postdoctoral appointments in pharmacology in the United Kingdom and the United States. Additionally, Wyeth has promoted Bernard Poussot to president and vice chairman. In addition to Mr. Poussot’s current responsibilities for Wyeth Pharmaceuticals and Wyeth R&D, he has assumed leadership for the Wyeth Consumer Healthcare and Fort Dodge Animal Health divisions of Wyeth. Mr. Poussot, 54, began his career at Wyeth in 1986 and most recently served as executive VP, Wyeth. Raymond Russo Schering-Plough Names VP, Global Cholesterol Marketing Raymond Russo has been promoted to VP of global cholesterol marketing at Schering-Plough, a global, science-based healthcare company with headquarters in Kenilworth, N.J. Most recently, Mr. Russo was Schering-Plough’s VP of U.S. cholesterol marketing. He has been with the company since 1982. He has an MBA in accounting and B.A. in economics from Rutgers University. Dr. Patrick Vallance GSK Appoints Drug Discovery Head GlaxoSmithKline, Philadelphia, a research-based pharmaceutical company, has named Patrick Vallance, M.D., senior VP, drug discovery. He succeeds Allan Baxter, who was appointed senior VP, medicines development. Dr. Vallance, who is based in the United Kingdom, has served on GSK’s R&D advisory board since 2004. He previously was the head of the division of medicine. He earned his scientific and medical degrees at the University of London. Biotech POOL William N. Anderson Scott Carmer Dr. Pamela M. Klein Dr. Mary B. Sliwkowski Genentech Appoints VPs Genentech, a biotechnology company based in South San Francisco, Calif., has named William N. Anderson to VP, sales and marketing, immunology. In this newly created position, Mr. Anderson, 39, is responsible for leading the sales and marketing activities for the company’s immunology products and pipeline. He joins Genentech from Biogen Idec, where he most recently was VP and general manager of the neurology business unit. He has a B.S. in chemical engineering from the University of Texas, Austin, and M.S. degrees in management and chemical engineering from the Massachusetts Institute of Technology. Scott Carmer has been appointed VP, sales and marketing, Rituxan Immunology. He is responsible for sales and marketing of Rituxan, as well as commercialization of new immunology products. Mr. Carmer, 41, joins Genentech from Amgen, where he was most recently global therapeutic area head in the global inflammatory disorders group. He has a B.S. in biology from the University of Kentucky. Pamela M. Klein, M.D., has been promoted to VP, clinical oncology, hematology, and HER family. Dr. Klein, 44, oversees the clinical science and medical science liaison groups, while continuing to chair the Development Review Committee for all HER family/B-cell activities. Dr. Klein previously was senior director of clinical oncology. Before joining Genentech in 2001, she was at the National Cancer Institute (NCI), where she was research director of the NCI-Navy Breast Care Center. Dr. Klein has a B.S. in cell and molecular biology from California State University, Northridge, and an M.D. from Loyola University’s Stritch School of Medicine. Genentech has also appointed Mary B. Sliwkowski, Ph.D., to VP, regulatory affairs, chemistry manufacturing and controls. She is responsible for the filings of biologic licensing applications, new drug applications, and investigational new drug applications, as well as regulatory submissions for contract manufacturing organization operations. Dr. Sliwkowski, 51, has been promoted to this newly created position from her previous role as senior director, regulatory affairs, product manufacturing, and regulatory submissions operations. She has been with Genentech since 1985. She has a B.S. in chemistry from the University of Delaware and a doctorate in biochemistry from North Carolina State University. Dr. Juergen Lasowski NPS Names Senior VP NPS Pharmaceuticals, Salt Lake City, has appointed Juergen Lasowski, Ph.D., as senior VP of corporate development. NPS discovers, develops, and commercializes small molecules and recombinant proteins as drugs, primarily for the treatment of metabolic, bone and mineral, and central nervous system disorders. Dr. Lasowski is responsible for the company’s corporate and business development efforts. He has come to NPS from Sanofi-Aventis, where he was VP of business development and strategy. Dr. David R. Parkinson Biogen Idec Appoints Head of Oncology R&D David R. Parkinson, M.D., has been named senior VP, oncology research and development, for Biogen Idec, Cambridge, Mass., a biotechnology company with a particular focus on oncology, neurology, and immunology therapeutics. Dr. Parkinson is based at the company’s San Diego office, where he oversees all oncology discovery research efforts. Additionally, he is charged with the development of the oncology pipeline. Previously, he was VP, oncology development, at Amgen. He has an M.D. from the University of Toronto Faculty of Medicine. David L. Stern Serono Names Executive VP, Metabolic Endocrinology David L. Stern has been promoted to executive VP, metabolic endocrinology, at Serono, Rockland, Mass., the U.S. subsidiary of global biotechnology company Serono SA. He manages all U.S. commercial operations for the company’s metabolic product portfolio, including sales, marketing, and medical-affairs functions. Previously, Mr. Stern was VP of marketing, metabolic endocrinology. Before joining Serono, he was director of reproductive marketing at Organon USA. Mr. Stern earned his MBA, with a concentration in international marketing and management, from Babson College. Additionally, he has a bachelor’s degree in biology, with a minor in economics, from Brandeis University. John J. Trizzino Mark C. Twyman MedImmune Adds Staff John J. Trizzino has been appointed VP of trade and distribution at MedImmune, Gaithersburg, Md. MedImmune is a biotechnology company focused on infectious disease, cancer, and inflammatory diseases. Mr. Trizzino is responsible for developing and implementing the strategies for distributing MedImmune’s products. Most recently, he was senior VP, business development, at ID Biomedical. He holds a B.S. degree from the C.W. Post Campus, Long Island University, and an MBA from New York University’s Leonard N. Stern School of Business. In other company news, Mark C. Twyman has been appointed to the newly created position of VP and general manager, vaccines. He is responsible for the commercial introduction and success of vaccines in MedImmune’s portfolio. Previously, Mr. Twyman worked for Merck’s Vaccine Division, where he was most recently VP, global pediatric franchise. He has a bachelor’s degree in economics from Dickinson College and an MBA from the Wharton School at the University of Pennsylvania. Biopharmaceutical POOL Dr. Stephen Arneric Neuromed Expands Executive Team Neuromed Pharmaceuticals has appointed Stephen Arneric, Ph.D., to its executive team as VP of research and preclinical development. Dr. Arneric is responsible for overseeing the company’s discovery and preclinical operations. Neuromed, Conshohocken, Pa., is a biopharmaceutical company developing next-generation chronic pain drugs. Dr. Arneric was most recently a senior director and head for central nervous systems biology at Pfizer’s Ann Arbor, Mich., laboratories. He has a Ph.D. in pharmacology from the University of Iowa. Dr. Xavier Frapaise Ocera Appoints Chief Medical Officer Xavier Frapaise, M.D., has been appointed chief medical officer of Ocera Therapeutics, a privately held, San Diego-based biopharmaceutical company focused on gastrointestinal and liver diseases. Dr. Frapaise previously was corporate officer and VP of R&D at TAP Pharmaceutical Products. Dr. Frapaise graduated from the Rene Descartes Medical School. Dr. Michael J. Gast Genaera Appoints Clinical R&D Leader Michael J. Gast, M.D., Ph.D., has been appointed senior VP, clinical research and development, at Genaera, a biopharmaceutical company in Plymouth Meeting, Pa. Dr. Gast was Genaera’s chief medical officer during the first half of 2005, before leaving briefly to pursue personal interests. He returned to the company in November as a full-time consultant. Dr. Gast brings more than 30 years of medical and pharmaceutical experience to the company. Previously, he spent 11 years at Wyeth Pharmaceuticals, most recently as VP of scientific affairs for Wyeth Global Medical Affairs. He has an M.D. from The Ohio State University College of Medicine and a Ph.D. in molecular biology from Washington University. Dr. Martine George Dr. Ramona Lloyd GPC Biotech Adds Senior Executives GPC Biotech, an oncology-focused biopharmaceutical company based in Martinsried/Munich, Germany, has expanded its drug-development and commercialization management teams in its Princeton, N.J., office. Martine George, M.D., has been named senior VP, clinical development. Dr. George has joined GPC from Johnson & Johnson Pharmaceutical Research and Development, where she was senior VP, head of oncology. Ramona Lloyd, Ph.D., has been named VP, worldwide regulatory affairs and quality compliance. She previously was VP of global regulatory operations for Bristol-Myers Squibb. Dr. Michael J. Hensley Dr. Drew Jones Avigen Makes Management Changes Avigen, Alameda, Calif., a biopharmaceutical company focused on treating serious neurological disorders, has appointed Michael J. Hensley, M.D., as head of regulatory affairs. Previously, he held senior clinical and regulatory positions at Chiron, Connaught Laboratories, Schering- Plough, Pharmacyclics, and Quintiles. Additionally, Drew Jones, M.D., has been appointed senior director of clinical affairs. Dr. Jones most recently was VP of clinical development and regulatory affairs for Galileo Pharmaceuticals. Dr. John L. Ryan Aveo Appoints Chief Medical Officer Aveo Pharmaceuticals, Cambridge, Mass., a biopharmaceutical company developing novel cancer medicines, has appointed John L. Ryan, Ph.D., M.D., as chief medical officer. Dr. Ryan is responsible for clinical strategy and development of Aveo’s pipeline. He joins the company after 11 years at Wyeth, where he most recently was senior VP of translational research. He earned his bachelor’s, master’s, and doctoral degrees from Yale University and his M.D. from the University of California, San Diego. Specialty POOL Gilbert Godin Biovail Names Senior VP Biovail, a specialty pharmaceutical company based in Mississauga, Ontario, has hired Gilbert Godin as senior VP, technical operations/drug delivery. He is responsible for the company’s product-development capability as well as manufacturing and contract-development services. Mr. Godin most recently served as president of MDS Pharma. He has an MBA from Concordia University and an engineering degree from Sherbrooke University. Edward Schutter First Horizon Names Chief Commercial Officer First Horizon Pharmaceutical has appointed Edward Schutter as executive VP, chief commercial officer. Based in Alpharetta, Ga., First Horizon is a pharmaceutical company specializing in products for cardiology and women’s health. Mr. Schutter most recently was VP of global business development and licensing at Solvay Pharmaceuticals. He has a B.S. in pharmacy from Mercer University and an MBA from Kennesaw State University. Dr. John Thottathil New River Pharmaceuticals Names Chief Scientific Officer New River Pharmaceuticals, Radford, Va., has hired John Thottathil, Ph.D., as chief scientific officer. Dr. Thottathil leads the company’s research and discovery programs from its laboratories in Blacksburg, Va. Before joining New River, he spent more than four years at Abbott Laboratories as the director of core research and development chemistry, diagnostic division. He has a Ph.D. in organic chemistry from the Indian Institute of Science. Agency POOL Michelle Amari Anne Sovie Scott Whittier Seidler Bernstein Promotes Staff Michelle Amari has been promoted to senior account manager at Seidler Bernstein, Cambridge, Mass., a full-service marketing and communications agency specializing in healthcare and life sciences. She previously was account manager. Before joining Seidler Bernstein in 2004, she was an account manager at SRK Group. She has a B.S. in sport management from the University of Massachusetts at Amherst. Anne Sovie also has been promoted to account supervisor from senior account manager. In this new role, she oversees all aspects of the Bayer HealthCare Diagnostics account. Ms. Sovie joined Seidler Bernstein in 1997 from Summit Technology. She has a B.S. in business management from Colby-Sawyer College. Scott Whittier has been promoted to senior writer, responsible for working closely with both clients and the account team to develop strategic creative. He joined Seidler Bernstein in 2003 and most recently served the agency as a writer. Previously, he was a copywriter for Lehman Millet, Christopher Thomas, and Baldwin Stone. He has a B.A., with distinction, in advertising from the University of North Carolina at Chapel Hill. Pamela Anderson Dr. Gary Bird Roberta Bongers Claudia Kanaszyc Frank Macaluso Donahoe Purohit Miller Adds Staff Donahoe Purohit Miller (DPM), Chicago, a full-service healthcare marketing and communications company, has added staff in several departments. Pamela Anderson has been hired as senior art director. Most recently, Ms. Anderson worked as a freelance art director. Gary Bird, Ph.D., joined DPM as a clinical communications specialist. He has a doctorate degree in neuroscience from the University of Leeds. Roberta Bongers has been appointed account executive. Previously, Ms. Bongers held senior account executive positions at Edelman Public Relations and The Reilly Group. Claudia Kanaszyc has been appointed program manager. She has joined the advertising agency from Prescott Medical, where she had an account executive role. Frank Macaluso has joined DPM’s creative team as senior art director/illustrator. Mr. Macaluso has 43 years of design experience, including work for clients such as 3M, Abercrombie & Kent, Baxter, Gillette, Quaker Oats, Morton Salt, and Sears. Jacqueline Ansel Marilyn Bashoff Shannon Coughlin GSW Adds Staff in New York GSW Worldwide, Westerville, Ohio, has made several new hires in its New York office. GSW, part of the inChord Communications division of inVentiv Health, is one of the largest healthcare ad agencies in the world. The agency has appointed Jacqueline Ansel as editor. Previously, she was a freelance editor with Saatchi & Saatchi, FCB Healthcare, and Adelphi. She has a bachelor’s degree from Rutgers University. Marilyn Bashoff has been named group copy supervisor. Most recently, Ms. Bashoff served as copy supervisor at Nelson Communications. She has a bachelor’s degree from Cornell University. Shannon Coughlin has been hired as senior account executive in GSW’s public-relations group. She previously was an account executive with Cooney Waters Group. Ms. Coughlin has a bachelor’s degree from Kansas State University. Donald W. Asselborn Paul J. Laki Jr. Barbara Nelson Craig Pace Patricia Wolfangel Leana Wood Access Communications Expands Sales Team Access Communications, a knowledge-based, client-oriented communications and marketing organization in Berkeley Heights, N.J., has hired six sales and client-service healthcare executives. Donald W. Asselborn has been appointed senior VP, new business development. He brings 16 years of pharmaceutical experience, most recently as the leader of direct-to-consumer and disease-awareness campaigns for Plavix at Sanofi-Synthelabo. Paul J. Laki Jr. has been appointed senior VP, government affairs. He has 23 years of pharmaceutical experience with Schering-Plough and Yamanouchi. He has a B.S. in pharmacy from St. John’s University School of Pharmacy. Barbara Nelson has been named VP of new business development, medical education, responsible for leading the strategic and tactical development of the company’s Medaccess division. She brings more than 12 years of medical and healthcare communications experience. She has a B.A. from Douglass College, Rutgers University. Craig Pace has been hired as VP of new business development. Before joining Access Communications, Mr. Pace was director of business development for Triple i/MediMedia. Patricia Wolfangel has been appointed senior VP of new business development. She has come to the agency after 13 years as a partner at the Zitter Group. Leana Wood has been named senior VP, new business development, Medaccess, West Coast. She is based at the new Medaccess offices in San Diego. She most recently served as U.S. director of marketing for Botox Cosmetic at Allergan. She earned her master’s in international business from DePaul University and her undergraduate degree in marketing from Indiana University. Gail Berlese Gabriel Fernandez- Obregon Jennifer Kiellar Osbaldo Rodriguez Carbon Expands with New Hires Gail Berlese has been named VP, associate creative director/art, at Carbon, Parsippany, N.J., a CommonHealth professional advertising and promotion agency serving emerging technology/specialty brands. Ms. Berlese previously spent 15 years at Torre Lazur McCann, where she most recently was VP, associate creative director/art. Gabriel Fernandez-Obregon has been named senior graphic designer. Previously, Mr. Fernandez-Obregon was a graphic designer and project manager at Resource Advantage Group. Jennifer Kiellar has been named account supervisor. Previously, she was an account manager at Cardinal Health. Osbaldo Rodriguez has been appointed art director. Most recently, he was at Integrated Communications as an assistant art director. Dyan Bryson Rhoda Dunn Isabelle Gauvry Kevin Hensil Steve Martino Vox Medica Makes Staff Changes Vox Medica, a Philadelphia-based healthcare communications company, has hired Dyan Bryson as VP, educational programs, of the Institute for Continuing Healthcare Education. Ms. Bryson previously was VP, business development, for MedLearning. She holds an MBA in pharmaceutical marketing from Saint Joseph’s University. Rhoda Dunn has transitioned from the agency’s marketing communications group into a new role as VP, marketing and business development. Ms. Dunn, a 2004 Healthcare Businesswomen’s Association Rising Star, holds a B.A. in English from the University of California, Davis. Vox Medica has hired Isabelle Gauvry as senior VP in the healthcare public-relations group. She most recently served as the director of national media relations for Porter Novelli. She is a graduate of the University of Pennsylvania. Kevin Hensil also has joined the agency’s healthcare public-relations group as senior account executive. He has come to Vox Medica from the Pennsylvania House of Representatives, where he was media project manager. A graduate of Westminster College, Mr. Hensil also completed the marketing communications diploma program at Elizabethtown College. Steve Martino has been appointed creative director in Vox Medica’s healthcare marketing communications group. He brings more than 20 years of advertising experience to the agency. He is a graduate of the University of Pennsylvania. John Clark Charles Di Stefano Janice Furie Xchange Expands Staff with New Hires Xchange, Parsippany, N.J., the relationship-marketing unit of CommonHealth, has hired John Clark as executive VP, managing director. In this role, Mr. Clark is responsible for the development and maintenance of key client relationships. Most recently, he was employed at GSW Worldwide, where he was responsible for developing professional and consumer CRM programs. Additionally, Charles Di Stefano has joined Xchange as VP, account director. In this role, Mr. Di Stefano is responsible for facilitating the strategy of creative and effective integrated CRM programs. Most recently, he was a management supervisor at Rapp Collins Worldwide. Janice Furie has been made an account supervisor. She previously was a marketing manager at Pfizer. Lisa DeSordi Mickey McDermott Neil Paulino Ferguson Restructures Creative Management Team Ferguson, Parsippany, N.J., has re-envisioned its creative management team. Ferguson is the founding professional advertising and promotion agency of CommonHealth. Lisa DeSordi, a 19-year CommonHealth veteran, has been appointed senior VP, creative director/art. In this newly developed role, Ms. DeSordi is responsible for the management, mentorship, and motivation of all creative staff on the art side. Mickey McDermott has taken on the newly created position of chief strategic officer for the creative unit. In addition to his role as executive creative director/copy, Mr. McDermott oversees all copy staff and their output while working with all Ferguson clients to identify new, strategic areas of brand opportunity. Additionally, Ferguson has hired Neil Paulino to the newly created position of senior VP, director of creative services. Mr. Paulino is an industry veteran with more than 20 years of experience spanning several therapeutic categories. Anne Devereux CEO Appointed at LLNS and TBWA WorldHealth LLNS and TBWA Worldwide have appointed Anne Devereux as CEO of LLNS and CEO of TBWA WorldHealth. LLNS is a healthcare communications agency and part of the Diversified Agency Services (DAS) division of the Omnicom Group. TBWA WorldHealth is one of the largest global marketing services networks dedicated to healthcare and lifestyle brands. Both agencies are based in New York. Ms. Devereux, 44, most recently helped build the DTC communications practice of BBDO New York. Michelle Jones S&R Communications Names Speakers Program Manager Michelle Jones has been promoted to speakers program manager at S&R Communications, a full-service healthcare marketing and communications company based in Durham, N.C. Ms. Jones joined the agency in 2005 as event coordinator and most recently served as speakers program team leader/assistant manager. Brad Lewis Stonefly Promotes Client Advisor Brad Lewis has been named senior VP/client advisor at Stonefly Communications, Westerville, Ohio, a customer-centric healthcare advertising agency and part of the inChord Communications division of inVentiv Health. He provides strategic marketing, creative counsel, and guidance to brand teams. Mr. Lewis has been promoted from his previous position as VP/client advisor. Before joining Stonefly in 2005, he was VP/account director at GSW Worldwide. He has an MBA from Keller Graduate School of Management. Dr. Jennifer Scott Ogilvy Expands Senior Management Team Jennifer Scott, Ph.D., has joined Ogilvy Public Relations Worldwide, a New York-based marketing-communications firm, as managing director of insights and research. In this role, Dr. Scott drives the growth and development of the agency’s primary research capabilities. Before joining Ogilvy PR, she was president of StrategyOne. She has a B.A. in politics and psychology from the University of Natal in South Africa and a Ph.D. in politics from Oxford University. CRO POOL David Gessner Michael Raquet Bruce Teplitzky PRA Hires and Promotes David Gessner has been named senior VP, business development, at PRA International, a global clinical development organization with headquarters in Reston, Va. He manages a group of sales teams focused on emerging biotech and pharmaceutical clients. Mr. Gessner has come to PRA from Duke Clinical Research Institute, bringing more than 12 years of experience in the CRO industry. PRA has hired Michael Raquet as senior VP of business development, responsible for managing sales teams focused on large pharmaceutical clients. He previously spent 20 years in senior management positions at IMS Health. He has an MBA from Boston University and a B.S. from Villanova University. Additionally, PRA has expanded the role of Bruce Teplitzky, executive VP, business development. In addition to overseeing marketing, proposals, and contracts, Mr. Teplitzky now leads the company’s global sales activities. He been with PRA for 10 years and has replaced Jim Powers, executive VP, business development, who retired after 18 years with the company. Dr. Frank G. Lobeck Dr. Harindranath (Hari) Nagaradona Kendle Adds Staff Kendle has appointed Frank G. Lobeck, Pharm.D., as clinical project group leader. Dr. Lobeck is responsible for the direction of Phase I-III clinical development projects for the company’s biopharmaceutical customers. Based in Cincinnati, Kendle is a global, full-service clinical research organization. Dr. Lobeck brings to the CRO more than 23 years experience, most recently as director of development operations at Pfizer. He holds doctoral and B.S. degrees in pharmacy from Wayne State University. Kendle also has hired Harindranath (Hari) Nagaradona, Ph.D., as senior regulatory consultant. Based in Rockville, Md., Dr. Nagaradona assists customers with questions regarding biologics, nonclinical studies, genomics, validations, and regulatory strategies. He earned his Ph.D. in biochemistry from the Indian Institute of Science, and he has a graduate certificate in information systems from Johns Hopkins University. Dr. Colleen McAuliffe Omnicare Promotes Senior VP, Project Management Omnicare Clinical Research, King of Prussia, Pa., a full-service, global CRO, has promoted Colleen McAuliffe, Ph.D., to senior VP, project management, Americas. Dr. McAuliffe joined Omnicare Clinical Research in 2001 and most recently held the position of VP, global strategic account business operations leader. She has a Ph.D. from the University of North Carolina at Greensboro, a master’s of public health from the University of North Carolina at Chapel Hill, an M.A. from Montclair State University, an M.S. from Long Island University, and an MBA from LaSalle University. Dr. Denis R. Miller Parexel Clinical Research Services Adds Staff Denis R. Miller, M.D., has been appointed senior medical director at Parexel Clinical Research Services, a unit of the global biopharmaceutical services company Parexel International. A foremost oncology and hematology expert, Dr. Miller serves as clinical practice leader and provides consultation to clients sponsoring clinical trials in hematology and oncology. Over the past 10 years, Dr. Miller has held senior positions in pharmaceutical R&D and clinical oncology at clinical research organizations and pharmaceutical companies, including Roche and Johnson & Johnson. Board certified in pediatrics and pediatric hematology/oncology, Dr. Miller holds A.B. and M.D. degrees from Cornell University. Additionally, he was a Fulbright Scholar at the University of London, St. Mary’s Medical School. Dr. Thomas Rosanske James Streeter PPD Builds Team Thomas Rosanske, Ph.D., has joined PPD, Wilmington, N.C., as executive director of product development analytical services for the contract research organization’s cGMP laboratory. He is responsible for strategic planning for the lab’s core business, as well as for establishing new services offerings. Dr. Rosanske was most recently executive director of pharmaceutical sciences at Beckloff Associates. He holds a bachelor’s degree in chemistry from the University of Wisconsin-Oshkosh, as well as a master’s in analytical chemistry and a doctorate in pharmacy from the University of Wisconsin-Madison. James Streeter has been named executive director of electronic data capture (EDC). Mr. Streeter brings to PPD more than 17 years of related experience, most recently as senior director of global clinical data services at Pfizer. Medical-Education POOL Karen Farrington Curry Rockefeller Promotes Senior Program Manager The Curry Rockefeller Group, Tarrytown, N.Y., has promoted Karen Farrington to senior program manager in the CRG Connect division. Curry Rockefeller develops thought-leader-focused medical education. Dr. Asya Kogan HealthSTAR Hires Managing Director for Oncology HealthSTAR Educational Systems (HES), Woodbridge, N.J., has appointed Asya Kogan, Pharm.D., as senior VP, managing director, oncology. Dr. Kogan is responsible for helping to build the oncology division at HES, a healthcare marketing services network. She previously was an assistant professor of pharmacy practice at the Long Island University School of Pharmacy and Health Sciences. Dr. Kogan has a B.S. and a doctorate in pharmacy from Rutgers University College of Pharmacy. Additionally, she completed a residency in internal medicine at Mount Sinai Hospital. Service POOL Michelle Pearsall Samantha Weinstein PharmaTech Expands Clinical Staff PharmaTech Solutions, a Wilmington N.C.-based clinical-development services provider, has hired Michelle Pearsall as director of clinical operations. Ms. Pearsall was previously senior project manager, registries and epidemiology, at Charles River Laboratories. She has a B.A. in biology from the University of North Carolina, Wilmington. Samantha Weinstein has been named clinical project manager. She spent the past five years working at PPD. Ms. Weinstein has a B.A. in English from the University of North Carolina, Wilmington. David Spaight MDS Pharma Services Appoints President MDS, a Toronto-based provider of enabling products and services for the global life-sciences markets, has appointed David Spaight as president of its MDS Pharma Services division. Most recently, he was senior VP, global sales and marketing, at Fisher Scientific Products. Mr. Spaight earned both his B.S. in chemistry and his MBA from the University of Michigan. Technology POOL Leandro Crespo Nicole Davis Mark Gordon Staci Hutchinson Advanced Health Media Makes Key Appointments Advanced Health Media (AHM) has appointed Leandro Crespo as director of application development. Based in Union, N.J., AHM provides technology solutions for compliant pharmaceutical meetings, speaker programs, and healthcare professional interactions. Mr. Crespo is responsible for the operational functions of the company’s software-development organization based in Chesapeake, Va. He began with the company as a consultant in 1999. Nicole Davis has been promoted to senior director of operations. She oversees staffing, resource allocation, process design and improvement, quality execution, and operational initiative management. She joined AHM in 2002 and most recently was senior operations manager. Mark Gordon has been promoted to director of operations, responsible for ensuring adherence to the company’s high standards of quality. He originally joined AHM in 2000 as an account manager. Staci Hutchinson has been promoted to senior operations manager. She joined AHM in 2001 and most recently was an operations manager. Earl Hulihan Medidata Adds VP, Global Regulatory Affairs Earl Hulihan has joined Medidata Solutions as VP of global regulatory affairs and quality assurance, responsible for ensuring compliance with U.S. and international clinical and quality regulations. Medidata, New York, is a global provider of electronic clinical data capture, management, and reporting solutions. Previously, Mr. Hulihan was senior VP of regulatory consulting services at META Solutions. He holds a master’s degree in education and bachelor’s degrees in education and the sciences. Pekka Keskiivari CRF Appoints Chief Technology Officer Pekka Keskiivari has been named chief technology officer at CRF, Waltham, Mass., a developer of electronic patient reported outcomes (ePRO) and wireless data collection solutions. In this role, Mr. Keskiivari oversees ongoing development of CRF’s product offerings and nurtures, supports, and manages technological innovation throughout the company. Previously, Mr. Keskiivari worked for TeliaSonera Finland. He has an M.Sc. in electrical engineering from Helsinki University of Technology, where he is currently working toward his Ph.D. on advanced query languages. John Loucks Relsys Hires Global Sales VP John Loucks has been named VP of global sales for Relsys International, an Irvine, Calif.-based provider of software solutions for adverse-event reporting, pharmacovigilance, and risk management. Operating from the firm’s Philadelphia office, he directs all sales activities for Relsys. He spent 12 years with the SAS Institute, most recently as the national sales director for the life-sciences division. Eric Valentine Octagon Appoints VP Octagon Research Solutions, Wayne, Pa., a process-centric solutions provider, has appointed Eric Valentine to VP of its clinical-data operations division. He is spearheading the company’s efforts in CDISC conversions. Please send your personnel announcements to firstname.lastname@example.org.